Corrigendum: EGLN2 attenuates ovarian cancer malignancy via ferroptosis activation

Authors

Institutions

Publication Details

Journal
Neoplasma
Published
2025-11-14
DOI
https://doi.org/10.4149/neo_2025_250411n162cor
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Corrigendum: EGLN2 attenuates ovarian cancer malignancy via ferroptosis activation

Yue Wu, Dake Li, Xiaoli Wu, Shengyuan Jiang et al.
Neoplasma
Ferroptosis and cancer prognosis
article

Corrigendum: EGLN2 attenuates ovarian cancer malignancy via ferroptosis activation

Yue Wu, Dake Li, Xiaoli Wu, Shengyuan Jiang, Kaipeng Xie, Haiyan Chen
article en

Abstract

No abstract available for this paper.
NeoplasmaVol. 72(05)
Nanjing Maternity and Child Health Care Hospital (CN), Nanjing Medical University (CN)
Openalex Percentile: Top 51%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.